Colorectal Cancer Clinical Trials
Colorectal Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for colorectal Cancer. Corterve aggregates actively recruiting Colorectal Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Colorectal Cancer studies
- Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")NCT07411599PHASE1, PHASE2M.D. Anderson Cancer CenterHouston, Texas
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsNCT04657068PHASE1, PHASE2Artios Pharma LtdBirmingham, Alabama
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701PHASE1PfizerFayetteville, Arkansas
- Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsNCT06445062PHASE1, PHASE2Revolution Medicines, Inc.Chandler, Arizona
- KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal CancerNCT06411691PHASE1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore, Maryland
- Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal CancerNCT07527858PHASE2Gilead SciencesNorth Haven, Connecticut
- Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C MutationNCT06252649PHASE3AmgenChandler, Arizona
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal CancerNCT07321106PHASE1Cartography BiosciencesPhoenix, Arizona
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesNCT04847063PHASE1National Cancer Institute (NCI)Bethesda, Maryland
- Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal CancerNCT06654037PHASE1National Cancer Institute (NCI)Irvine, California
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal CancersNCT06562192PHASE1Novartis PharmaceuticalsBirmingham, Alabama
- Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and EffectivenessNCT05691491PHASE1, PHASE2National Cancer Institute (NCI)Irvine, California
Colorectal Cancer trials by state
Colorectal Cancer trials by metro
Frequently asked questions
- How do I find recruiting Colorectal Cancer clinical trials?
- Corterve aggregates actively recruiting Colorectal Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Colorectal Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Colorectal Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.